Scoggin Management LP Kronos Bio, Inc. Transaction History

Scoggin Management LP

  • $460 Million
  • Q3 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.24 - $1.92 $192,487 - $298,045
155,232 New
155,232 $266,000

Others Institutions Holding KRON

# of Institutions
2
Shares Held
886K
Call Options Held
0
Put Options Held
0
View Full List

About Kronos Bio, Inc.

KRON Quotes by TradingView
  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $50M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Scoggin Management LP Portfolio

Follow Scoggin Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scoggin Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Scoggin Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email